Literature DB >> 27242198

The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.

Xiao-Fei Ma1, Jing Sun1, Chong Qiu1, Yi-Fan Wu1, Yi Zheng1, Min-Zhi Yu1, Xi-Wei Pei1, Lin Wei1, Yu-Jie Niu1, Wen-Hao Pang1, Zhen-Jun Yang2, Jian-Cheng Wang3, Qiang Zhang1.   

Abstract

In our previous study, a H-shape gemini-like cationic lipid (ssGLCL, formerly named as CLD), composed of two hydrophilic lysine heads and two hydrophobic oleyl alcohol tails with a bridge of the redox-active disulfide-bond, had been synthesized and used as a nanocarrier for delivering small interfering RNAs (siRNAs) into cells. In order to further elucidate the role of disulfide (-S-S-) bridge on the activity of ssGLCL based siRNA delivery, a comparable ccGLCL bridged with a non-reducible carbon-carbon bond was synthesized and used as control in this study. Both two H-shape GLCL molecules could individually self-assemble into cationic nanoparticles in water phase and complex with negatively-charged siRNA into nanoplexes with particle size of ~200nm and zeta potential of ~ +30mV, and exhibit effective siRNA delivery both in vitro and in vivo. Investigation of internalization pathway displayed that both ssGLCL/siRNA and ccGLCL/siRNA nanoplexes were predominantly internalized into MCF-7 cells by the clathrin-mediated endocytosis pattern. Although a lower cellular uptake of siRNA was found in the human breast cancer MCF-7 cells, the ssGLCL/siRNA nanoplexes could exhibit similar or even stronger down-regulation effects on the targeted EGFR mRNA and protein in MCF-7 cells when compared to the ccGLCL/siRNA nanoplexes. Furthermore, mechanistic study showed that the enhanced down-regulation effects of ssGLCL/siRNA nanoplexes on targeted mRNA and protein were probably attributed to the increased release of siRNA from lysosomes to cytoplasm following the cleavage of redox-active disulfide-bridge in ssGLCL. Therefore, we believed that the redox-active H-shape ssGLCL could be a potential nanocarrier towards improving siRNA delivery.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biodegradation; Disulfide bond; Gemini-like lipid; Nanocarrier; siRNA delivery

Mesh:

Substances:

Year:  2016        PMID: 27242198     DOI: 10.1016/j.jconrel.2016.05.051

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

Review 1.  Transfection by cationic gemini lipids and surfactants.

Authors:  M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal:  Medchemcomm       Date:  2018-07-17       Impact factor: 3.597

2.  Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; S Thayumanavan
Journal:  Biochemistry       Date:  2021-01-11       Impact factor: 3.162

3.  Delivery Pathway Regulation of 3',3″-Bis-Peptide-siRNA Conjugate via Nanocarrier Architecture Engineering.

Authors:  Jing Sun; Chong Qiu; Yiping Diao; Wei Wei; Hongwei Jin; Yi Zheng; Jiancheng Wang; Lihe Zhang; Zhenjun Yang
Journal:  Mol Ther Nucleic Acids       Date:  2017-11-14       Impact factor: 8.886

4.  Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells.

Authors:  Zhaoxiu Zhou; Shuang Liu; Yanfen Zhang; Xiantao Yang; Yuan Ma; Zhu Guan; Yun Wu; Lihe Zhang; Zhenjun Yang
Journal:  Int J Nanomedicine       Date:  2017-10-04

5.  Novel formulation of c-di-GMP with cytidinyl/cationic lipid reverses T cell exhaustion and activates stronger anti-tumor immunity.

Authors:  Xiaotong Yu; Jing Yu; Hong Dai; Chenyun Deng; Xudong Sun; Sijie Long; Zhujun Jiang; Hongyan Jin; Zhu Guan; Zhenjun Yang
Journal:  Theranostics       Date:  2022-09-11       Impact factor: 11.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.